Healthcare AINVIDIA's GPU Infrastructure Powers New Wave of AI-Native Drug Discovery PlatformsVia News Editorial Team•Aug 8, 2026
Healthcare AIMindWalk Patents Biology 'Meaning Layer' as NVIDIA Wires Foundation Models Into Drug R&DVia News Editorial Team•Aug 1, 2026
Healthcare AIMindWalk's HYFT Database Hits 660 Million Biological Patterns as Pharma Outsources AI R&DVia News Editorial Team•Jul 31, 2026
Healthcare AINovo Nordisk Outsources Parkinson's Program as NVIDIA's BioNeMo Turns Drug Discovery Into InfrastructureVia News Editorial Team•Jun 25, 2026
Healthcare AINVIDIA's BioNeMo Anchors Drug Discovery Stack as Pharma Outsources R&D to AI PlatformsVia News Editorial Team•Jun 19, 2026
Healthcare AINVIDIA BioNeMo Becomes Pharma's AI Backbone as Novo Nordisk Outsources Parkinson's R&DVia News Editorial Team•Jun 9, 2026
Biotech AINVIDIA BioNeMo Locks In Pharma Partnerships as Novo Nordisk Outsources Parkinson's Therapy to AI SpecialistVia News Editorial Team•Jun 5, 2026
Healthcare AINVIDIA BioNeMo Locks In Enterprise Drug Discovery as Pharma Shifts R&D to AI InfrastructureVia News Editorial Team•Jun 1, 2026
Healthcare AINVIDIA's BioNeMo Locks In Pharma Giants as AI Drug Discovery Becomes Table StakesVia News Editorial Team•May 31, 2026
Healthcare AINVIDIA's BioNeMo Becomes Drug Discovery's Default AI Backbone as Big Pharma Outsources Frontier BiologyVia News Editorial Team•May 21, 2026
Healthcare AINVIDIA's BioNeMo Emerges as Core Infrastructure Layer as Pharma Rebuilds R&D Around AI PlatformsVia News Editorial Team•May 18, 2026
Healthcare AINVIDIA's BioNeMo Becomes Drug Discovery Infrastructure as Eli Lilly, Thermo Fisher Sign OnVia News Editorial Team•May 16, 2026
Healthcare AINVIDIA BioNeMo Signs Eli Lilly and Thermo Fisher Deals, Becomes Pharma AI Infrastructure LayerVia News Editorial Team•May 1, 2026
Healthcare AIAmgen Merges R&D and AI Under One Executive as Pharma Makes Generative AI Core InfrastructureVia News Editorial Team•Apr 30, 2026
Healthcare AINVIDIA BioNeMo Locks In Thermo Fisher and Eli Lilly as Biotech AI Platform War Heats UpVia News Editorial Team•Apr 29, 2026
Healthcare AINVIDIA BioNeMo Platform Secures Pharma Partnerships with Lilly and Thermo FisherVia News Editorial Team•Apr 21, 2026
Healthcare AINVIDIA BioNeMo Platform Anchors Wave of Pharma AI Partnerships and Foundation Model LaunchesVia News Editorial Team•Apr 18, 2026
Healthcare AINVIDIA BioNeMo Platform Locks In Eli Lilly and Thermo Fisher for AI Drug Discovery InfrastructureVia News Editorial Team•Apr 17, 2026
Healthcare AINVIDIA's BioNeMo Secures Lilly, Thermo Fisher as Biotech AI Startups Launch Competing PlatformsVia News Editorial Team•Apr 12, 2026
Healthcare AINVIDIA Anchors Biotech AI Platform Through Lilly and Thermo Fisher PartnershipsVia News Editorial Team•Apr 11, 2026